Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Craven House Capital Plc investment portfolio
Craven House Capital Plc has made numerous investments in companies such as Garimon, Honeydog, and Bio Vitos Medical within the Software & IT sector.
vc
Portfolio
4
Team
0
Portfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Bio Vitos Medical Limited Bio Vitos Medical Limited holds the licence to market the patented heart drug Succifer (also known as Inofer), focusing on commercialising this cardiovascular therapy. | Software & IT | London | Confirmed | 2025-03-12 |
| Garimon Limited | Software & IT | London | Confirmed | 2025-03-04 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
2 more similar investors hiddenSign up to unlock →
Shareholding changes (5)
Craven House Capital Plc's positions across portfolio companies2023
- ORDINARY 0 → 299
- ORDINARY 14,708,700 → 17,558,940